12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·11/21/2024 21:06:11

Listen to the news

Gainers

SCWorx (NASDAQ:WORX) shares moved upwards by 71.4% to $1.68 during Thursday's pre-market session. The market value of their outstanding shares is at $2.7 million.
Conduit Pharmaceuticals (NASDAQ:CDT) stock rose 55.36% to $0.14. The market value of their outstanding shares is at $14.7 million.
Cidara Therapeutics (NASDAQ:CDTX) shares rose 28.96% to $19.5. The market value of their outstanding shares is at $137.4 million.
Semler Scientific (NASDAQ:SMLR) stock rose 27.46% to $75.55. The company's market cap stands at $548.9 million.
Biodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 16.88% to $4.5. The market value of their outstanding shares is at $65.3 million.
DarioHealth (NASDAQ:DRIO) stock increased by 14.1% to $0.89. The market value of their outstanding shares is at $30.3 million.

Losers

Pyxis Oncology (NASDAQ:PYXS) stock fell 43.5% to $2.16 during Thursday's pre-market session. The company's market cap stands at $128.3 million.
Perspective Therapeutics (AMEX:CATX) shares declined by 27.23% to $4.49. The market value of their outstanding shares is at $303.4 million.
Kura Oncology (NASDAQ:KURA) stock decreased by 25.52% to $11.85. The company's market cap stands at $921.5 million.
BioLine Rx (NASDAQ:BLRX) stock decreased by 22.42% to $0.42. The company's market cap stands at $33.8 million.
Silexion Therapeutics (NASDAQ:SLXN) stock declined by 20.0% to $0.27. The market value of their outstanding shares is at $3.8 million.
Assembly Biosciences (NASDAQ:ASMB) stock fell 11.06% to $13.36. The market value of their outstanding shares is at $84.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English